ProLindac: Phase II started

Access began an open-label, European Phase II trial to evaluate 1,400 mg/m 2 IV ProLindac in combination with 175 mg/m 2 paclitaxel given on day 1 of a 3-week cycle for up to 6 cycles in 30 patients. ...